Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HI-LIGHT pilot study of intraoperative fluorescence detection in colorectal peritoneal carcinomatosis
NL-OMON27201Active, not recruiting
- Sponsor
- University Medical Center Groningen
- Start
- Jul 2014
- Modality
- Cytotoxic ADCs → Antibody-Drug Conjugates (ADCs) → Antibody Conjugates → Antibody-Based Therapeutics, Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Open-label, single-arm trial of bevacizumab-IRDye800CW in colorectal cancer (CRC) and peritoneal carcinomatosis (PC), sponsored by University Medical Center Groningen. Primary endpoints: Sensitivity and specificity of intraoperative fluorescence imaging, Fluorescent signal localization and semiquantification and 1 more. Started Jul 2014; status: active, not recruiting.
02
Drugs
bevacizumab-IRDye800CW
03
Conditions
colorectal cancer (CRC)peritoneal carcinomatosis (PC)
Beyond the preview
Go deeper on NL-OMON27201.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON27201.